Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1973 2
1975 2
1976 1
1979 3
1980 1
1983 1
1984 1
1987 4
1988 3
1989 3
1991 1
1992 2
1993 3
1995 1
1996 4
1997 2
1998 2
1999 2
2000 2
2001 1
2002 2
2003 7
2004 10
2005 3
2006 3
2007 4
2008 2
2009 2
2010 3
2011 2
2012 2
2013 8
2014 6
2015 3
2016 2
2017 3
2018 2
2019 5
2020 6
2021 8
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, Vyzhga Y, Marzan K, Grebenkina L, Tirosh I, Imundo L, Jerath R, Kingsbury DJ, Sozeri B, Vora SS, Prahalad S, Zholobova E, Butbul Aviel Y, Chasnyk V, Lerman M, Nanda K, Schmeling H, Tory H, Uziel Y, Viola DO, Posner HB, Kanik KS, Wouters A, Chang C, Zhang R, Lazariciu I, Hsu MA, Suehiro RM, Martini A, Lovell DJ; Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG). Ruperto N, et al. Among authors: spindler a. Lancet. 2021 Nov 27;398(10315):1984-1996. doi: 10.1016/S0140-6736(21)01255-1. Epub 2021 Nov 9. Lancet. 2021. PMID: 34767764 Clinical Trial.
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment.
Fleischmann R, Schiff M, van der Heijde D, Ramos-Remus C, Spindler A, Stanislav M, Zerbini CA, Gurbuz S, Dickson C, de Bono S, Schlichting D, Beattie S, Kuo WL, Rooney T, Macias W, Takeuchi T. Fleischmann R, et al. Among authors: spindler a. Arthritis Rheumatol. 2017 Mar;69(3):506-517. doi: 10.1002/art.39953. Arthritis Rheumatol. 2017. PMID: 27723271 Free PMC article. Clinical Trial.
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Ramanan AV, Quartier P, Okamoto N, Foeldvari I, Spindler A, Fingerhutová Š, Antón J, Wang Z, Meszaros G, Araújo J, Liao R, Keller S, Brunner HI, Ruperto N; JUVE-BASIS investigators; Paediatric Rheumatology International Trials Organisation. Ramanan AV, et al. Among authors: spindler a. Lancet. 2023 Aug 12;402(10401):555-570. doi: 10.1016/S0140-6736(23)00921-2. Epub 2023 Jul 6. Lancet. 2023. PMID: 37423231 Clinical Trial.
Viral Burden and Clearance in Asymptomatic COVID-19 Patients.
Gunatilaka AB, Marco N, Read GH, Sweeney M, Regan G, Tsang C, Abdulrahman L, Ampabathina S, Spindler A, Lu SS, Schink E, Gatti R, Ingersoll C, Telesca D, Weidhaas JB. Gunatilaka AB, et al. Among authors: spindler a. Open Forum Infect Dis. 2022 Mar 16;9(5):ofac126. doi: 10.1093/ofid/ofac126. eCollection 2022 May. Open Forum Infect Dis. 2022. PMID: 35493121 Free PMC article.
Pediatric COVID-19 Delirium: Case Report of 2 Adolescents.
Bauer SC, Moral F, Preloger E, Spindler A, Roman M, Logan A, Sandage SJ, Manak C, Mitchell M. Bauer SC, et al. Among authors: spindler a. WMJ. 2021 Jul;120(2):131-136. WMJ. 2021. PMID: 34255953 Free article.
Clinical and immunogenetic characterization in psoriatic arthritis patients.
Schneeberger EE, Citera G, Rodríguez Gil G, Granel A, Arturi A, Rosemffet GM, Maldonado Cocco JA, Berman A, Spindler A, Morales VH. Schneeberger EE, et al. Among authors: spindler a. Clin Rheumatol. 2015 Aug;34(8):1413-8. doi: 10.1007/s10067-014-2739-3. Epub 2014 Jul 11. Clin Rheumatol. 2015. PMID: 25008283
Active lupus in Argentina: Results of a multicenter and national registry.
Quintana RM, García M, Garcia L, Gobbi C, Alba P, Bellomio V, Roverano S, Alvarez AP, Graf CE, Pisoni C, Spindler A, Gomez C, Figueredo HM, Papasidero S, Paniego R, de la Vega MC, Civit E, Gonzalez Lucero L, Martire MV, Aguila Maldonado R, Gordon S, Micelli M, Nieto R, Rausch G, Alarcón GS, Pons-Estel B, Pons-Estel G; SLE Study Group from the RELESSAR Registry. Quintana RM, et al. Among authors: spindler a. Lupus. 2023 Nov;32(13):1555-1560. doi: 10.1177/09612033231209601. Epub 2023 Nov 8. Lupus. 2023. PMID: 37936393
Safety and Efficacy of Poseltinib, Bruton's Tyrosine Kinase Inhibitor, in Patients With Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, 2-part Phase II Study.
Genovese MC, Spindler A, Sagawa A, Park W, Dudek A, Kivitz A, Chao J, Chan LSM, Witcher J, Barchuk W, Nirula A. Genovese MC, et al. Among authors: spindler a. J Rheumatol. 2021 Jul;48(7):969-976. doi: 10.3899/jrheum.200893. Epub 2020 Dec 15. J Rheumatol. 2021. PMID: 33323529 Clinical Trial.
119 results